menu search

Navigating acumen's alzheimer's risk and reward

Acumen Pharmaceuticals' ACU193 shows promise as a potential treatment for early-stage Alzheimer's Disease, targeting amyloid beta oligomers with a mor...

October 3, 2023, 11:03 am

Novo nordisk receives us regulatory go ahead for kidney treatment

Europe's largest drugs company, Novo Nordisk (NYSE:NVO), told investors its once-monthly injection, Ri...

October 3, 2023, 3:24 am

Micron solutions, inc. board announces proposal for stock splits

Micron Solutions, Inc. Board Announces Proposal to Enact Stock Splits in Plan to voluntarily delist from OTC Markets FITCHBURG, Mass., Oct. 02, 2023 (...

October 3, 2023, 12:16 am

Roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd

Basel, 02 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) will present new data for OCREVUS® (ocrelizumab) and investigational Bruton's tyrosine ki...

October 2, 2023, 1:00 am

Thermo fisher scientific: transforming healthcare leadership post-covid-19 pandemic

Thermo Fisher Scientific is a leading research and development company and provider of laboratory products and services headquartered in Waltham. On A...

September 30, 2023, 8:29 am

Why shares of structure therapeutics are soaring on friday

Structure's weight-loss drug candidate is of the same class as Mounjaro and Wegovy, but while those drugs must be ...

September 29, 2023, 12:50 pm

Sharps technology issues letter to shareholders covering the announced asset purchase agreement to acquire injectez prefillable syringe manufacturing facility and the associated $400 million 10-year p

Transformative acquisition and purchase order enables Sharps to commercialize its innovative copolymer prefillable syringe systems to the healthcare m...

September 28, 2023, 2:52 pm

One world lithium signs definitive agreement to acquire two patent applications for a lithium extraction technology

One World Lithium Inc. (CSE:OWLI, OTCQB:OWRDF) told investors it has signed an Assignment and License Agreement with MatterGreen LLC (MG), an arm's le...

September 28, 2023, 10:03 am

Gsk lifts growth ambitions for hiv business on long-acting drug

GSK on Thursday lifted its medium-term growth forecast for its HIV drugs business ViiV, encouraged by strong sales of long-acting ...

September 28, 2023, 9:05 am

Scpharmaceuticals: furoscix, charting a bright future with fda's nod for ckd

Positive FDA feedback for Furoscix's label expansion into chronic kidney disease signals the potential for significant market growth. Introduction of ...

September 27, 2023, 12:40 am

Amazon's shares gain as $4b deal with ai firm anthropic announced

E-commerce and cloud computing giant Amazon is set to inject $4 billion into Anthropic, an artificial i...

September 25, 2023, 10:46 pm

Ultragenyx launches evkeeza® (evinacumab for injection) in canada for the treatment of homozygous familial hypercholesterolemia (hofh)

Evkeeza is a first-in-class medicine approved by Health Canada, the U.S. Food and Drug Administration (FDA) and European Commission (EC) to treat an u...

September 25, 2023, 9:13 pm

Coherus biosciences' new injector treatment for cancer patients rejected by fda

Coherus BioSciences said Monday that the U.S. Food and Drug Administration rejected its regulatory submission for a new on-body ...

September 25, 2023, 8:53 am

Pakistan bans roche cancer drug pending probe into patients' blindness

Pakistan's drug regulator said on Monday it had temporarily banned the use of a cancer medication distributed by Swiss pharmaceutical company Roche pe...

September 25, 2023, 5:20 am

Xrp news: ripple’s battle with sec tests investor resilience

XRP navigates through turbulent waters as Ripple’s SEC lawsuit and its pending appeal inject a dose o...

September 24, 2023, 1:41 am

Ars pharmaceuticals vs. aquestive therapeutics; neffy crl creates an opportunity for investing in both

Both ARS Pharmaceuticals and Aquestive Therapeutics are developing non-injectable epinephrine products ...

September 22, 2023, 7:18 pm

Protagonist therapeutics: there are reasons behind johnson & johnson's optimism

Protagonist Therapeutics, Inc.'s oral IL-23 drug for psoriasis, JNJ-2113, must show non-inferior efficacy to Johnson & Johnson's ...

September 22, 2023, 3:35 pm

Eli lilly set to dominate obesity drug market into the next decade, analysts say

Eli Lilly & Co. LLY, -3.42% is best positioned to dominate the fast-growing U.S. market for obesity drugs into the 2030s, BMO Capital Markets analysts...

September 22, 2023, 8:27 am

Pboc sets usd/ cny reference rate for today at 7.1729 (vs. estimate at 7.3009)

The People's Bank of China set the onshore yuan (CNY) reference rate for the trading session ahead.USD/CNY is the onshore yuan. Its permitted to trade...

September 22, 2023, 1:15 am

Hygh: not properly compensated for rising credit defaults

iShares Interest Rate Hedged High Yield Bond ETF allows investors to bet on the direction of credit spreads. Contrary to my expectations, HYGH has per...

September 21, 2023, 2:26 am


Search within

Pages Search Results: